Chemed Corporation (CHE) 의 후행 P/E는 20.5, 선행 P/E 15.8. 후행 이익수익률은 4.87%, 선행 이익수익률 6.32%. PEG 0.53 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $172.76.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 64/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 24.2 | 15.81 | 5.01 | 1.67 | 0.63% |
| 2017 | 39.7 | -4.98 | 7.22 | 2.34 | 0.45% |
| 2018 | 22.1 | 0.20 | 7.69 | 2.55 | 0.41% |
| 2019 | 31.9 | 4.21 | 9.65 | 3.62 | 0.28% |
| 2020 | 26.6 | 0.59 | 9.43 | 4.09 | 0.25% |
| 2021 | 30.9 | -2.15 | 13.30 | 3.88 | 0.27% |
| 2022 | 30.5 | -12.46 | 9.54 | 3.57 | 0.29% |
| 2023 | 32.3 | 3.88 | 7.94 | 3.89 | 0.27% |
| 2024 | 26.4 | 2.40 | 7.11 | 3.27 | 0.34% |
| 2025 | 23.2 | -2.78 | 6.29 | 2.43 | 0.51% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $6.48 | $1.58B | $108.74M | 6.9% |
| 2017 | $5.86 | $1.67B | $98.18M | 5.9% |
| 2018 | $12.23 | $1.78B | $205.54M | 11.5% |
| 2019 | $13.31 | $1.94B | $219.92M | 11.3% |
| 2020 | $19.48 | $2.08B | $319.47M | 15.4% |
| 2021 | $16.85 | $2.14B | $268.55M | 12.6% |
| 2022 | $16.53 | $2.13B | $249.62M | 11.7% |
| 2023 | $17.93 | $2.26B | $272.51M | 12% |
| 2024 | $19.89 | $2.43B | $302M | 12.4% |
| 2025 | $18.42 | $2.53B | $265.24M | 10.5% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $23.88 | $23.77 – $23.97 | $2.67B | $2.66B – $2.68B | 2 |
| 2027 | $26.62 | $26.07 – $27.17 | $2.83B | $2.82B – $2.85B | 2 |
| 2028 | $28.90 | $28.75 – $29.06 | $3B | $3B – $3B | 1 |
